Business Standard

Suven Life Sciences

Pharma shares shine; Dr Reddy's, FDC, Glenmark, Suven trade at record highs

Shares of Wockhardt hit a multi-year high of Rs 943.20, zooming 65 per cent in past nine trading days.

Pharma shares shine; Dr Reddy's, FDC, Glenmark, Suven trade at record highs
Updated On : 03 Jul 2024 | 3:01 PM IST

Suven Pharma stock can surge up to 19% from here; check key levels

Technical charts suggest that Suven Pharma may trade with a positive bias in the near-term, provided the stock manages to hold above these key support levels.

Suven Pharma stock can surge up to 19% from here; check key levels
Updated On : 15 Apr 2024 | 2:40 PM IST

Will pharma stocks continue their dream rally in FY25?

PRESCRIPTION FOR CAUTION: Analysts sound alarm on valuations after past year's recovery

Will pharma stocks continue their dream rally in FY25?
Updated On : 07 Mar 2024 | 12:11 AM IST

CCI clears Berhyanda's 76% stake acquisition in Suven Pharmaceuticals

The Competition Commission of India (CCI) on Thursday said it has cleared Berhyanda Ltd's acquisition of a 76.10 per cent stake in pharmaceutical firm Suven Pharmaceuticals Ltd. Berhyanda Ltd is a wholly-owned subsidiary of Berhyanda Midco Ltd, which is an affiliate of Advent International Corporation. The proposed combination relates to the acquisition by Berhyanda Ltd for up to 76.10 per cent of the voting share capital of Suven Pharmaceuticals Ltd, by way of a share purchase agreement dated December 26, 2022, and pursuant to the mandatory open offer in compliance with Sebi's SAST (Substantial Acquisition of Shares and Takeovers) regulations, according to an official release. Suven Pharmaceuticals Ltd is a biopharmaceutical company that offers its services to global pharmaceutical and agrochemical majors. Deals beyond a certain threshold require approval from the regulator, which keeps a tab on unfair business practices in the marketplace.

CCI clears Berhyanda's 76% stake acquisition in Suven Pharmaceuticals
Updated On : 20 Apr 2023 | 9:32 PM IST

We aim to be one of India's top CDMO, API players: Advent's Shweta Jalan

'Suven alone has multiple engines of growth across all segments and a strong pipeline of Phase 3 and late Phase 2 molecules'

We aim to be one of India's top CDMO, API players: Advent's Shweta Jalan
Updated On : 26 Dec 2022 | 9:59 PM IST

Sensex, Nifty recoup losses, end flat; auto stocks dip, PB Fintech gains 8%

CLOSING BELL: The S&P BSE Sensex ended with a marginal loss of 88 points, while the Nifty held the 18,300-level on Friday.

Sensex, Nifty recoup losses, end flat; auto stocks dip, PB Fintech gains 8%
Updated On : 18 Nov 2022 | 3:50 PM IST

Stocks to watch: RIL, Tata Motors, Nykaa, ABFRL, Equitas SFB, Suven Life

Stocks to watch today: Tata Motors bagged order for 1,000 buses from Haryana Roadways; ABFRL inked pact with Galeries Lafayette to open luxury department stores in India

Stocks to watch: RIL, Tata Motors, Nykaa, ABFRL, Equitas SFB, Suven Life
Updated On : 18 Nov 2022 | 8:04 AM IST

Suven starts Phase 3 trial for first home-grown Alzheimer's drug

Clinical trial randomisation is the process of assigning patients by chance to groups that receive different treatments

Suven starts Phase 3 trial for first home-grown Alzheimer's drug
Updated On : 17 Nov 2022 | 10:50 PM IST

Suven Life freezes at 20% upper circuit as board to mull rights issue

The stock had hit a 52-week low of Rs 62 on June 20, 2022, and has corrected 50 per cent from its record high level of Rs 124 touched on October 8, 2021

Suven Life freezes at 20% upper circuit as board to mull rights issue
Updated On : 21 Jun 2022 | 3:25 PM IST

Stocks to Watch: Telecom, LIC Hsg Fin, KEC Intl, Suven Life, IIFL Finance

Stocks to Watch Today: Indiabulls Housing Finance and RBL Bank are the two stocks in F&O ban period on Tuesday.

Stocks to Watch: Telecom, LIC Hsg Fin, KEC Intl, Suven Life, IIFL Finance
Updated On : 21 Jun 2022 | 7:56 AM IST

Sebi disposes of proceedings against Suven Life Sciences, others

Markets regulator Sebi on Thursday disposed of proceedings against Suven Life Sciences Ltd, Jasti Family Trust and four other individuals, including the firm's chairman and CEO Venkateshwarlu Jasti

Sebi disposes of proceedings against Suven Life Sciences, others
Updated On : 28 Oct 2021 | 11:57 PM IST

Select pharma shares rally; Suven Pharma up 13%, Laurus nears record high

Healthcare companies to post decent growth in revenues in Q3FY21

Select pharma shares rally; Suven Pharma up 13%, Laurus nears record high
Updated On : 14 Jan 2021 | 1:44 PM IST

Suven Life Sciences tumbles 20% as SUVN-502 misses target in phase-2 trial

As part of the study, Suven tested the drug as a unique triple combination with Aricept (donepezil) and Namenda (memantine) on 564 patients in the US for at least one year

Suven Life Sciences tumbles 20% as SUVN-502 misses target in phase-2 trial
Updated On : 02 Dec 2019 | 10:54 AM IST

Suven gets US court's approval to buy assets of Rising Pharmaceuticals

The company has completed a 'stalking horse agreement' as mandated by a bankruptcy court to buy the assets of Rising Pharmaceuticals, Suven Life Sciences said in a regulatory filing

Suven gets US court's approval to buy assets of Rising Pharmaceuticals
Updated On : 13 Apr 2019 | 5:31 PM IST

Suven Life Sciences enters asset purchase agreement to buy Rising Pharma

This potential acquisition of Rising's assets would transform Shore Suven Pharma into a strong US generic pharmaceutical company

Suven Life Sciences enters asset purchase agreement to buy Rising Pharma
Updated On : 08 Mar 2019 | 4:26 PM IST

Suven Life Sciences gets patent for neuro drug in Australia, Singapore

These patents are valid through 2036, the company said in a BSE filing

Suven Life Sciences gets patent for neuro drug in Australia, Singapore
Updated On : 16 Jan 2019 | 4:52 PM IST

Suven Life Sciences nears record high; stock surges 30% in one week

The stock hit a 52-week high of Rs 338, rallied 88% in past four months, trading close to its record high of Rs 339 touched on April 15, 2015 on the BSE.

Suven Life Sciences nears record high; stock surges 30% in one week
Updated On : 11 Sep 2018 | 10:51 AM IST

Suven gets patents from Europe, South Korea for new chemical entity

The NCE will be useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Huntington's disease, Parkinson's and schizophrenia

Suven gets patents from Europe, South Korea for new chemical entity
Updated On : 16 Jul 2018 | 12:20 PM IST

Suven Life gets product patents from India, Singapore, South Korea, Israel

These patents are valid through 2031, 2034, 2034 and 2036 respectively, the company said in a BSE filing

Suven Life gets product patents from India, Singapore, South Korea, Israel
Updated On : 04 Jul 2018 | 12:27 PM IST

Suven Life up 6% as Pashamylaram's unit completes USFDA inspection

The stock moved higher by 6% to Rs 192 on the BSE in noon deal after the company's Pashamylaram's unit successfully completed the USFDA inspection

Suven Life up 6% as Pashamylaram's unit completes USFDA inspection
Updated On : 07 May 2018 | 3:04 PM IST